Nova Msc Bhd
KLSE:NOVA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.258
0.435
|
| Price Target |
|
We'll email you a reminder when the closing price reaches MYR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Nova Msc Bhd
Nova MSC Bhd.operates as an investment holding company, which engages in software research and development and the provision of e-business solutions through the sale of application software and professional services for software customization and implementation. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2003-08-19. The firm operates through the E-Business Solutions segment. Its geographical segments include Malaysia and Singapore. The Company’s in-house products for the healthcare and government sectors include Pavo, Fornax, Vesalius, Avicenna and EyScan. The Company’s subsidiaries include novaHEALTH Pte. Ltd., novaCITYNETS Pte. Ltd., novaSOLUTIONS (Philippines), Inc. and Dex-Lab Pte. Ltd.
Nova MSC Bhd.operates as an investment holding company, which engages in software research and development and the provision of e-business solutions through the sale of application software and professional services for software customization and implementation. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2003-08-19. The firm operates through the E-Business Solutions segment. Its geographical segments include Malaysia and Singapore. The Company’s in-house products for the healthcare and government sectors include Pavo, Fornax, Vesalius, Avicenna and EyScan. The Company’s subsidiaries include novaHEALTH Pte. Ltd., novaCITYNETS Pte. Ltd., novaSOLUTIONS (Philippines), Inc. and Dex-Lab Pte. Ltd.
